1. Home
  2. DLPN vs ATHA Comparison

DLPN vs ATHA Comparison

Compare DLPN & ATHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DLPN
  • ATHA
  • Stock Information
  • Founded
  • DLPN 1996
  • ATHA 2011
  • Country
  • DLPN United States
  • ATHA United States
  • Employees
  • DLPN N/A
  • ATHA N/A
  • Industry
  • DLPN Other Consumer Services
  • ATHA Medicinal Chemicals and Botanical Products
  • Sector
  • DLPN Consumer Discretionary
  • ATHA Health Care
  • Exchange
  • DLPN Nasdaq
  • ATHA Nasdaq
  • Market Cap
  • DLPN 12.6M
  • ATHA 14.8M
  • IPO Year
  • DLPN N/A
  • ATHA 2020
  • Fundamental
  • Price
  • DLPN $1.19
  • ATHA $0.38
  • Analyst Decision
  • DLPN Strong Buy
  • ATHA Hold
  • Analyst Count
  • DLPN 1
  • ATHA 3
  • Target Price
  • DLPN $5.00
  • ATHA $0.50
  • AVG Volume (30 Days)
  • DLPN 580.9K
  • ATHA 119.5K
  • Earning Date
  • DLPN 08-13-2025
  • ATHA 11-06-2025
  • Dividend Yield
  • DLPN N/A
  • ATHA N/A
  • EPS Growth
  • DLPN N/A
  • ATHA N/A
  • EPS
  • DLPN N/A
  • ATHA N/A
  • Revenue
  • DLPN $51,257,243.00
  • ATHA N/A
  • Revenue This Year
  • DLPN $9.05
  • ATHA N/A
  • Revenue Next Year
  • DLPN $15.42
  • ATHA N/A
  • P/E Ratio
  • DLPN N/A
  • ATHA N/A
  • Revenue Growth
  • DLPN 4.84
  • ATHA N/A
  • 52 Week Low
  • DLPN $0.75
  • ATHA $0.22
  • 52 Week High
  • DLPN $1.78
  • ATHA $0.83
  • Technical
  • Relative Strength Index (RSI)
  • DLPN 51.86
  • ATHA 45.90
  • Support Level
  • DLPN $1.14
  • ATHA $0.36
  • Resistance Level
  • DLPN $1.21
  • ATHA $0.39
  • Average True Range (ATR)
  • DLPN 0.07
  • ATHA 0.02
  • MACD
  • DLPN 0.00
  • ATHA -0.00
  • Stochastic Oscillator
  • DLPN 77.27
  • ATHA 49.75

About DLPN Dolphin Entertainment Inc.

Dolphin Entertainment Inc is an independent entertainment marketing and production company. It provides strategic marketing and publicity services to many of the top brands, both individual and corporate, in the motion picture, television, music, gaming, culinary, hospitality, and lifestyle industries. It operates in two reportable segments: Entertainment publicity and marketing and Content production. It generates the majority of its revenue from the Entertainment publicity and marketing segment which provides clients with diversified marketing services, including public relations, entertainment and hospitality content marketing, strategic marketing consulting, and content production of marketing materials.

About ATHA Athira Pharma Inc.

Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug candidate designed to enhance the activity of the neurotrophic hepatocyte growth factor (HGF) system; ATH-1020 a novel, orally available, next-generation small molecule drug candidate designed to positively modulate the neurotrophic HGF system; ATH-1105 is a novel, orally available, next-generation, small molecule drug candidate designed to positively modulate the neurotrophic HGF system.

Share on Social Networks: